Acid secretory capacity and plasma gastrin concentration after administration of omeprazole to normal subjects.
In a randomized double-blind study, two groups of eight healthy volunteers received either placebo or omeprazole 40 mg o.m. for 14 days. Fasting plasma gastrin concentration and peak acid output in response to a maximal intravenous dose of pentagastrin were measured before, during and after the 14 days of treatment. Omeprazole caused a 68% (mean) decrease in the peak acid output when measured 24 hours after the last dose, with a simultaneous increase in the fasting plasma gastrin concentration. When measured 1, 2, 3 and 8 weeks after cessation of treatment, there was no significant difference in the peak acid output between the two groups. The study demonstrates that there is no increase in the acid production capacity after 2 weeks of treatment with omeprazole. Thus it would appear that the rise in the plasma gastrin concentration during short-term treatment with omeprazole does not induce parietal cell hypertrophy or hyperplasia.
Sharma
B
B
Academic Department of Medicine, Royal Free Hospital School of Medicine, London, UK.
Axelson
M
M
Pounder
R P
RP
Lundborg
P
P
Ohman
M
M
Santana
A
A
Talbot
M
M
Cederberg
C
C
D000328:Adult; D004311:Double-Blind Method; D005744:Gastric Acid / Q000378:metabolism*; D005753:Gastric Mucosa / Q000166:cytology / Q000187:drug effects; D005755:Gastrins / Q000097:blood*; D006801:Humans; D008297:Male; D009853:Omeprazole / Q000009:adverse effects / Q000494:pharmacology*; D012016:Reference Values
D005755:Gastrins; D009853:Omeprazole